tirzepatide

Term ID

CHEBI:194186

Synonyms

L-tyrosyl-2-methylalanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-tyrosyl-L-seryl-L-isoleucyl-2-methylalanyl-L-leucyl-L-alpha-aspartyl-L-lysyl-L-isoleucyl-L-alanyl-L-glutaminyl-N(6)-(17-{[N-(19-carboxynonadeca
LY-3298176
LY3298176
Mounjaro

Definition

A 39-amino acid linear polypeptide which is conjugated to a C20 fatty diacid moiety via a linker connected to lysine-20. It is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 agonist used for the management of type 2 diabetes mellitus.

References

cas:2023788-19-2
drugbank:DB15171
kegg.drug:D11360
pubmed:30293770
pubmed:34681215
pubmed:34788445
pubmed:35333651
pubmed:35579691
pubmed:35658024
pubmed:35759552
pubmed:35760842
pubmed:35767712
pubmed:35773392
pubmed:35780672
pubmed:35802842
pubmed:35807558
pubmed:35830001
pubmed:35929468
pubmed:35949358
pubmed:35977865
pubmed:35983423
pubmed:36050763
pubmed:36152638
pubmed:36155186
pubmed:36157450
pubmed:36199834
pubmed:36200219
pubmed:36239652
pubmed:36239653
pubmed:36251836
pubmed:36313764
pubmed:36358930
pubmed:36478180
pubmed:36498958
pubmed:36516422
pubmed:36530219
pubmed:36569320
pubmed:36570276
pubmed:36575627
wikipedia.en:Tirzepatide

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from tirzepatide

Phenotype where environments contain tirzepatide

Phenotype modified by environments containing tirzepatide

Phenotype affecting tirzepatide

Human Disease Model